ANI PHARMACEUTICALS, INC (ANIP) Operating income 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual operating income history from SEC filings — each fiscal year as reported.
$111.1MFY2025 · since FY2016: $20.1M → $111.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $111.1M | +18922.8% |
| FY2024 | $584,000 | -98.8% |
| FY2023 | $47.0M | +233.1% |
| FY2022 | -$35.3M | +11.3% |
| FY2021 | -$39.8M | -148.5% |
| FY2020 | -$16.0M | -198.0% |
| FY2019 | $16.4M | -53.8% |
| FY2018 | $35.4M | +24.8% |
| FY2017 | $28.3M | +41.1% |
| FY2016 | $20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating marginANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →